Cargando…
Supercomputer simulation of the covalent inhibition of the main protease of SARS-CoV-2
Molecular modeling tools were applied to design a potential covalent inhibitor of the main protease (M(pro)) of the SARS-CoV-2 virus and to investigate its interaction with the enzyme. The compound includes a benzoisothiazolone (BZT) moiety of antimalarial drugs and a 5-fluoro-6-nitropyrimidine-2,4(...
Autores principales: | Nemukhin, A. V., Grigorenko, B. L., Lushchekina, S. V., Varfolomeev, S. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761045/ https://www.ncbi.nlm.nih.gov/pubmed/35068913 http://dx.doi.org/10.1007/s11172-021-3319-8 |
Ejemplares similares
-
Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection
por: Ge, Rui, et al.
Publicado: (2022) -
Model of the RNA Polymerase Complex of the SARS-CoV-2 Virus with Favipiravir
por: Polyakov, I. V., et al.
Publicado: (2021) -
Optimization of Cholinesterase-Based Catalytic Bioscavengers Against Organophosphorus Agents
por: Lushchekina, Sofya V., et al.
Publicado: (2018) -
Supercomputing, Docking and Quantum Mechanics in Quest for Inhibitors of Papain-like Protease of SARS-CoV-2
por: Sulimov, A. V., et al.
Publicado: (2021) -
Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
por: Kneller, Daniel W., et al.
Publicado: (2022)